Invention Application
- Patent Title: INHALATION FORMULATIONS OF 1'-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS
-
Application No.: US17222125Application Date: 2021-04-05
-
Publication No.: US20210330685A1Publication Date: 2021-10-28
- Inventor: Scott Ellis , Davin S. Rautiola , Dustin S. Siegel , Maria M. Toteva , Adelle A. Vandersteen
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/685
- IPC: A61K31/685 ; A61K9/00 ; A61K47/40 ; A61K31/675 ; A61K9/19 ; A61P31/14
Abstract:
The present disclosure provides pharmaceutical formulations of the compound of Formula I, Formula Ia, or Formula Ib, or a pharmaceutically acceptable salt thereof, and an aqueous vehicle. The pharmaceutical formulations of the disclosure are useful in treatment and prevention of viral infections in subjects in need thereof and are for administration by inhalation.
Public/Granted literature
- US11701372B2 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs Public/Granted day:2023-07-18
Information query
